Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)
TWD 102.5
(-2.38%)
TWD 102.5
(-2.38%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 128.04 Million TWD | -29.63% |
| 2022 | 181.96 Million TWD | -17.72% |
| 2021 | 221.16 Million TWD | 54.98% |
| 2020 | 142.7 Million TWD | 87.91% |
| 2019 | 75.94 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 174.6 Million TWD | 36.36% |
| 2023 FY | 128.04 Million TWD | -29.63% |
| 2023 Q4 | 128.04 Million TWD | -19.1% |
| 2023 Q2 | 158.27 Million TWD | -13.02% |
| 2022 Q4 | 181.96 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 95.586% |
| Level Biotechnology Inc. | 822.67 Million TWD | 84.435% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 80.737% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 76.666% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 96.712% |
| GlycoNex Incorporation | 1.55 Billion TWD | 91.754% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 89.113% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 82.894% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | 66.158% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 88.707% |
| Visgeneer Inc. | 397.17 Million TWD | 67.761% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 96.604% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 94.069% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 85.5% |
| Neith Corporation | 192.15 Million TWD | 33.362% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 97.898% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -74.076% |
| Enimmune corporation | 604.82 Million TWD | 78.829% |
| TaiRx, Inc. | 833.74 Million TWD | 84.642% |
| EirGenix Inc. | 11.16 Billion TWD | 98.853% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 77.659% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 92.522% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 96.44% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 87.811% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | 57.464% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | 51.618% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 70.977% |
| RBC Bioscience Corporation | 753.79 Million TWD | 83.013% |
| BiOptic Inc. | 613.77 Million TWD | 79.138% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 92.801% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 88.959% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 80.143% |
| VBI | 452.1 Million TWD | 71.677% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 95.851% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 95.878% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | 13.443% |
| NaviFUS Corp. | 490.53 Million TWD | 73.896% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 89.553% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 90.608% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 75.801% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 88.975% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 92.269% |
| AP Biosciences Inc | 890.75 Million TWD | 85.625% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 98.498% |
| 3D Global Biotech Inc. | 324.14 Million TWD | 60.497% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 90.399% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 95.277% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 99.167% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 68.789% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | 67.734% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 93.832% |
| TCI GENE Inc. | 1.16 Billion TWD | 89.018% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | 56.532% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 90.608% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 86.403% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 81.667% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 96.762% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 96.65% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 89.588% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 97.715% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 87.943% |
| Acepodia, Inc. | 6.81 Billion TWD | 98.122% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 96.654% |